Annexon, Inc.ANNXNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank60
5Y CAGR-14.1%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-14.1%/yr
Long-term compound
Percentile
P60
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 12.55% |
| Q2 2025 | -8.34% |
| Q1 2025 | 11.13% |
| Q4 2024 | 44.01% |
| Q3 2024 | 20.29% |
| Q2 2024 | 19.38% |
| Q1 2024 | -9.90% |
| Q4 2023 | -16.58% |
| Q3 2023 | -7.79% |
| Q2 2023 | -6.47% |
| Q1 2023 | 13.35% |
| Q4 2022 | 2.42% |
| Q3 2022 | -4.27% |
| Q2 2022 | 7.81% |
| Q1 2022 | -0.80% |
| Q4 2021 | -1.32% |
| Q3 2021 | 12.25% |
| Q2 2021 | 18.73% |
| Q1 2021 | 15.03% |
| Q4 2020 | 52.80% |
| Q3 2020 | 26.79% |
| Q2 2020 | -9.10% |
| Q1 2020 | 50.36% |
| Q4 2019 | -4.15% |
| Q3 2019 | 18.41% |
| Q2 2019 | 28.67% |
| Q1 2019 | 18.19% |
| Q4 2018 | 3.14% |
| Q3 2018 | -1.80% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |